Cart
sales@molnova.com
Tetrazine-Ph-NHCO-C3-NHS ester
CAS No. 1244040-64-9
Tetrazine-Ph-NHCO-C3-NHS ester( —— )
Catalog No. M27018 CAS No. 1244040-64-9
Tetrazine-Ph-NHCO-C3-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 140 | In Stock |
|
| 10MG | 230 | In Stock |
|
| 25MG | 462 | In Stock |
|
| 50MG | 672 | In Stock |
|
| 100MG | 945 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTetrazine-Ph-NHCO-C3-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionTetrazine-Ph-NHCO-C3-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionTetrazine-Ph-NHCO-C3-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1244040-64-9
-
Formula Weight398.379
-
Molecular FormulaC18H18N6O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (251.02 mM)
-
SMILESO=C(CCCC(=O)ON1C(=O)CCC1=O)NCc1ccc(cc1)-c1nncnn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Examorelin
Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?
-
DFO
DFO (9H-1,8-Diazafluoren-9-one) is used to find fingerprints on porous surfaces.1,8-diazafluoren-9-one (DFO) is used in the forensic field to enhance latent fingerprints deposited on porous surfaces due to the formation of fluorescent products by reacting with the amino acids present in the papillary exudate. DFO has been the most used because of its excellent enhancing properties.
-
Yadanzioside G
Yadanzioside G has antileukemic activity.
